Immunotherapy responsive neuropathic pain associated with LGI1 and CASPR2 antibodies

Immunotherapy responsive neuropathic pain associated with LGI1 and CASPR2 antibodies

Bibliographic Details
Main Authors:	Ramanathan, S, Davies, A, Uy, C, Tseng, M, Paneva, S, Michael, S, Varley, J, Binks, S, Themistocleous, A, Anziska, Y, Candalija, A, Soni, A, Hofer, M, Brilot, F, Dale, RC, Dawes, J, Rinaldi, S, Bennett, D, Irani, SR
Format:	Conference item
Language:	English
Published:	BMJ Publishing Group 2021

Similar Items

007 Immunotherapy responsive neuropathic pain associated with LGI1 and CASPR2 antibodies
by: Russell C Dale, et al.
Published: (2021-08-01)

Leucine-rich glioma-inactivated 1 versus contactin-associated protein-like 2 antibody neuropathic pain: clinical and biological comparisons
by: Ramanathan, S, et al.
Published: (2021)

LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes
by: Binks, S, et al.
Published: (2017)

Magnetic resonance imaging characteristics of LGI1-antibody and CASPR2-antibody encephalitis
by: Kelly, MJ, et al.
Published: (2024)

Distinct HLA associations of LGI1 and CASPR2-antibody diseases
by: Binks, S, et al.
Published: (2018)

The immunogenetics of LGI1- and CASPR2-antibody encephalitis: towards aetiology
by: Binks, S
Published: (2022)

CXCL13 levels in LGI1-and CASPR2-autoantibody syndromes
by: Michael, S, et al.
Published: (2019)

Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2
by: Michael, S, et al.
Published: (2020)

Hippocampal epileptogenesis in LGI1, CASPR2 and GABABR antibodies: preliminary findings
by: Romoli, M, et al.
Published: (2020)

Contactin-2 associated protein (CASPR2) autoimmune neurological conditions: Detailed clinical phenotype and antibody quantification
by: Varley, J, et al.
Published: (2017)

The distinct pattern of movement disorders in Caspr2 and LGI1 antibody associated autoimmune encephalitis
by: Goevert, F, et al.
Published: (2019)

Randomized placebo‐controlled trial of intravenous immunoglobulin in autoimmune LGI1/CASPR2 epilepsy
by: Dubey, D, et al.
Published: (2019)

Randomized placebo‐controlled trial of intravenous immunoglobulin in autoimmune LGI1/CASPR2 epilepsy
by: Dubey, D, et al.
Published: (2019)

Exploring the role of CASPR2 in neuropathic pain
by: Tseng, M
Published: (2023)

Immunotherapy-resistant neuropathic pain and fatigue predict quality-of-life in contactin-associated protein-like 2 antibody disease
by: Ceronie, B, et al.
Published: (2025)

Combining clinical and molecular heterogeneity within CASPR2-antibody mediated diseases: towards the underlying disease biology
by: Binks, S, et al.
Published: (2020)

Caspr2 antibodies in patients with thymomas.
by: Vincent, A, et al.
Published: (2010)

Phenotypic Spectrum of CASPR2 and LGI1 Antibodies Associated Neurological Disorders in Children
by: Yan Jiang, et al.
Published: (2022-04-01)

LGI1 and CASPR2-related Morvan syndrome - diagnostic challenges in a pediatric case
by: Elena Catalina Petrov, et al.
Published: (2023-06-01)

Origins and immunopathogenesis of autoimmune central nervous system disorders
by: Ramanathan, S, et al.
Published: (2023)

Vgkc is dead: long live lgi1- and caspr2-antibodies. intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies
by: Lang, B, et al.
Published: (2017)

Cognitive, neuropsychiatric and quality-of-life sequelae in LGI1-antibody disease demonstrates fatigue as the key determinant of wellbeing
by: Binks, S, et al.
Published: (2020)

Mechanisms of disease perpetuation and pathogenesis in autoantibody-mediated epilepsies with a focus on LGI1- and CASPR2-related syndromes
by: Michael, S
Published: (2022)

Isaacs Syndrome in A Patient with Positive CASPR2 And LGI1 Antibodies: A Case Report and Literature Review
by: Rasa Zafari, et al.
Published: (2024-04-01)

‘Less contented as a person’: an update from the LGI1-QoL study
by: Binks, S, et al.
Published: (2019)

Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis?
by: Irani, SR, et al.
Published: (2011)

‘Less contented as a person’: preliminary data from the LGI1-QoL study
by: Binks, S, et al.
Published: (2017)

Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis.
by: Tofaris, G, et al.
Published: (2012)

Improving clinical practice with an old friend from the neuroimmunology toolkit: acute corticosteroids in LGI1 antibody encephalitis
by: Irani, SR
Published: (2021)

Reply to: Hemichorea Associated with CASPR2 Antibody
by: Ritesh A. Ramdhani, et al.
Published: (2014-05-01)

LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis
by: Jang, Y, et al.
Published: (2018)

Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis.
by: Irani, SR, et al.
Published: (2011)

Paraneoplastic neurological syndromes: a practical approach to diagnosis and management
by: Binks, S, et al.
Published: (2021)

Hemichorea Associated with CASPR2 Antibody
by: Iryna Vynogradova, et al.
Published: (2014-05-01)

Comparative effects of domain-specific human monoclonal antibodies against LGI1 on neuronal excitability
by: Sell, J, et al.
Published: (2023)

Antibodies to the Caspr1/contactin-1 complex in chronic inflammatory demyelinating polyneuropathy
by: Pascual-Goni, E, et al.
Published: (2021)

LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis
by: Yoonhyuk Jang, et al.
Published: (2018-09-01)

Patient-derived antibodies reveal the subcellular distribution and heterogeneous interactome of LGI1
by: Ramirez-Franco, J, et al.
Published: (2022)

Understanding the role of Caspr2 in the developing cerebellum
by: Argent, L
Published: (2019)

Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms
by: Ramberger, M, et al.
Published: (2020)